Clinical trials
Active, not recruiting Phase 3 trials in Jordan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Hoffmann-La Roche | 2 |
| Janssen Research & Development, LLC | 2 |
| argenx | 2 |
| Amgen | 1 |
| Day One Biopharmaceuticals, Inc. | 1 |
| Immunic AG | 1 |
| Janssen Pharmaceutica N.V., Belgium | 1 |
| Janssen-Cilag Ltd. | 1 |
| NewAmsterdam Pharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 2 |
| Myeloproliferative Disorders | 2 |
| Anemia, Sickle Cell | 1 |
| Atherosclerosis | 1 |
| Breast Neoplasms | 1 |
| Colitis, Ulcerative | 1 |
| Crohn Disease | 1 |
| Hematologic Diseases | 1 |
| Hemoglobinuria, Paroxysmal | 1 |
| Leukemia | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.